Successful management of severe bronchial asthma exacerbated by anti‐PD‐L1 treatment: A report of two cases

Immune checkpoint inhibitors (ICIs) have been used for various carcinomas. However, immune‐related adverse events have been observed. There have been few reports of treatment with biologics for severe bronchial asthma induced by ICI; therefore, their efficacy is unknown. We report two cases of sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumi, Toshiyuki, Nagahisa, Yuta, Matsuura, Keigo, Sekikawa, Motoki, Yamada, Yuichi, Nakata, Hisashi, Chiba, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542805/
https://www.ncbi.nlm.nih.gov/pubmed/34721879
http://dx.doi.org/10.1002/rcr2.868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542805/
https://www.ncbi.nlm.nih.gov/pubmed/34721879
http://dx.doi.org/10.1002/rcr2.868

Ejemplares similares